SCHEMBL29629307

SCHEMBL29629307

Cc1cc(OC(=O)c2cn(C)nc2C)n(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.40
NAMPT P43490 1/20 0.39
MAPT P10636 5/20 0.39
KMT2A Q03164 2/20 0.39
ALOX15 P16050 1/20 0.39
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 3/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
ALPL P05186 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
MEN1 O00255 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30293897 0.78 NAMPT (0.44) GAANAMPTMAPTATMSMN1; SMN2
SCHEMBL11602961 0.77 MAPT (0.54) MAPTKMT2AALOX15RAB9ANPC1
SCHEMBL11601679 0.75 NPC1 (0.41) GAAMAPTKMT2AALOX15ATM
SCHEMBL28174741 0.74 SMN1; SMN2 (0.41) GAAMAPTKMT2AALOX15SMN1; SMN2
SCHEMBL11602887 0.74 MAPT (0.43) GAAMAPTKMT2AALOX15CYP1A2
SCHEMBL11601176 0.74 KMT2A (0.52) MAPTKMT2AALOX15SMN1; SMN2ALDH1A1
SCHEMBL3416368 0.74 SMN1; SMN2 (0.43) MAPTKMT2AALOX15SMN1; SMN2POLB
SCHEMBL27682646 0.74 SMN1; SMN2 (0.43) MAPTKMT2AALOX15SMN1; SMN2ALDH1A1
SCHEMBL841632 0.74 GAA (0.51) GAANAMPTMAPTKMT2AATM
SCHEMBL11600960 0.73 KMT2A (0.46) MAPTKMT2AALOX15SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12098150-B2 Crystal of heterocyclic amide compound and method for producing same NISSAN CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
EP-3939977-B1 CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL CORP (JP) 2024-05-08 EP disclosed
WO-2022138821-A1 DISPERSIBLE CONCENTRATED AGROCHEMICAL FORMULATION 日産化学株式会社 2022-06-30 WO disclosed
US-20220153736-A1 CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL CORPORATION (JP) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153736-A1 CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME DDT, HDHD5, AADAC GAA 595/4885NAMPT 1070/4885MAPT 2577/4885
US-12098150-B2 Crystal of heterocyclic amide compound and method for producing same DDT, HDHD5, AADAC GAA 595/4885NAMPT 1070/4885MAPT 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.